All Pharma News
Mendus to present NK cell program progress at the Innate Killer Summit

Mendus to present NK cell program progress at the Innate Killer Summit
GLOBENEWSWIRE
19 Mar 2024
Share Share
The exercise period for warrants of series TO3 commences today

The exercise period for warrants of series TO3 commences today
GLOBENEWSWIRE
15 Mar 2024
Share Share
Mendus shareholders declare their intention to exercise warrants of series TO3

Mendus shareholders declare their intention to exercise warrants of series TO3
GLOBENEWSWIRE
15 Mar 2024
Share Share
Mendus provides business update and outlook for vididencel program

Mendus provides business update and outlook for vididencel program
GLOBENEWSWIRE
12 Mar 2024
Share Share
Mendus to participate in upcoming industry conferences

Mendus to participate in upcoming industry conferences
GLOBENEWSWIRE
27 Feb 2024
Share Share
Mendus to hold Business Update event on March 12

Mendus to hold Business Update event on March 12
GLOBENEWSWIRE
23 Feb 2024
Share Share
Mendus AB Year-end Report for 2023

Mendus AB Year-end Report for 2023
GLOBENEWSWIRE
14 Feb 2024
Share Share
Invitation to presentation of Mendus™ year-end report for 2023

Invitation to presentation of Mendus™ year-end report for 2023
GLOBENEWSWIRE
09 Feb 2024
Share Share
Mendus to participate in several investor and industry conferences in January

Mendus to participate in several investor and industry conferences in January
GLOBENEWSWIRE
08 Jan 2024
Share Share
Mendus announces clinical pipeline update

Mendus announces clinical pipeline update
GLOBENEWSWIRE
22 Dec 2023
Share Share